Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Sep 12, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
TL;DR
DRL filed a 6-K, just administrative stuff, no big news.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on September 12, 2024, to report information as a foreign private issuer. The filing confirms the company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, India, and that it files annual reports under Form 20-F. No specific financial transactions or material events were detailed in this particular filing.
Why It Matters
This filing serves as a routine update for investors and regulators, confirming the company's reporting status and administrative details.
Risk Assessment
Risk Level: low — This filing is a standard procedural report and does not contain new material financial information or strategic changes.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-000998 (accession_number) — Filing identifier
- 20240912 (date) — Filing date
- 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India (address) — Principal executive office
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used by Dr. Reddy's Laboratories Limited to submit information to the SEC.
When was this Form 6-K filed?
The filing was made on September 12, 2024.
Where is Dr. Reddy's Laboratories Limited's principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, 500 034, India.
Does Dr. Reddy's Laboratories Limited file annual reports under Form 20-F or 40-F?
The company indicates it files annual reports under cover of Form 20-F.
What is the SIC code for Dr. Reddy's Laboratories Limited?
The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-12 15:05:02
Filing Documents
- drr0669_6k.htm (6-K) — 14KB
- drr0669_ex99-1.htm (EX-99.1) — 57KB
- drr0669_ex99-1img01.jpg (GRAPHIC) — 2KB
- drr0669_ex99-1img02.jpg (GRAPHIC) — 11KB
- drr0669_ex99-1img03.jpg (GRAPHIC) — 799KB
- drr0669_ex99-1img04.jpg (GRAPHIC) — 447KB
- drr0669_ex99-1img05.jpg (GRAPHIC) — 268KB
- drr0669_ex99-1img06.jpg (GRAPHIC) — 10KB
- drr0669_ex99-1img07.jpg (GRAPHIC) — 12KB
- 0001575872-24-000998.txt ( ) — 2206KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 12, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3